-+ 0.00%
-+ 0.00%
-+ 0.00%

BRIEF-Biontech And Oncoc4 Updated Data Showing Gotistobart Nearly Doubled Median Overall Survival Versus Standard-Of-Care Chemotherapy In Previously Treated Squamous Non-Small Cell Lung Cancer Patients

路透·09/14/2026 08:04:41

登录查看新闻详情